Metabolite

3 clinical trials · Condition

Record	Firm	Date
Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally. (NCT01735240)	AstraZeneca	2012-12-01

Every clearance here is in the API, with alerts when new ones post.